News
November 6, 2024
GlycoMimetics Announces New Uproleselan Clinical Data Will Be Presented at ASH Annual Meeting
October 29, 2024
GlycoMimetics Enters Into Acquisition Agreement With Crescent Biopharma
October 29, 2024
GlycoMimetics Announces National Cancer Institute Phase 2/3 Study of Uproleselan Did Not Meet Primary Endpoint
Events
There are currently no upcoming events.
Partnering
Collaborations are vital to the success of our business.
To drive our proprietary programs forward, we have developed significant alliances with leading academics, governmental organizations and pharmaceutical/ biotechnology companies.
Learn More